scispace - formally typeset
Search or ask a question
Institution

University of Düsseldorf

EducationDüsseldorf, Germany
About: University of Düsseldorf is a education organization based out in Düsseldorf, Germany. It is known for research contribution in the topics: Population & Transplantation. The organization has 25225 authors who have published 49155 publications receiving 1946434 citations.


Papers
More filters
Journal ArticleDOI
TL;DR: Patients treated with biologic agents have a higher a priori risk of infection, however, the data suggest that this risk is increased by treatment with tumor necrosis factor inhibitors.
Abstract: Objective To estimate the incidence rates of serious and nonserious infections in patients with rheumatoid arthritis (RA) who start treatment with a biologic agent, and to compare these rates with those in patients with RA who receive conventional treatment Methods Patients enrolled in the German biologics register between May 2001 and September 2003 were included Treating rheumatologists assessed adverse events and serious adverse events All adverse events and serious adverse events experienced within 12 months after study entry were analyzed Propensity score methods were applied to estimate which part of a rate increase was likely to be attributable to differences in patient characteristics Results Data were available for 512 patients receiving etanercept, 346 patients receiving infliximab, 70 patients receiving anakinra, and 601 control patients treated with disease-modifying antirheumatic drugs The total number of adverse events per 100 patient-years was 226 (95% confidence interval [95% CI] 187–272) among patients receiving etanercept, 283 (95% CI 231–347) among patients receiving infliximab, and 68 (95% CI 50–94) among controls (P < 00001) Significant differences in the rate of serious adverse events were also observed For patients receiving etanercept, those receiving infliximab, and controls, the total numbers of serious adverse events per 100 patient-years were 64 (95% CI 45–91), 62 (95% CI 40–95), and 23 (95% CI 13–39), respectively (P = 00016) After adjusting for differences in the case patient mix, the relative risks of serious adverse events were 22 (95% CI 09–54) for patients receiving etanercept and 21 (95% CI 08–55) for patients receiving infliximab, compared with controls Conclusion Patients treated with biologic agents have a higher a priori risk of infection However, our data suggest that this risk is increased by treatment with tumor necrosis factor inhibitors

669 citations

Journal ArticleDOI
TL;DR: HDL is identified as a carrier of bioactive lysophospholipids that regulate vascular tone via S1P3-mediated NO release and induces vasodilation in isolated aortae via intracellular Ca2+ mobilization and Akt-mediated eNOS phosphorylation.
Abstract: HDL is a major atheroprotective factor, but the mechanisms underlying this effect are still obscure. HDL binding to scavenger receptor-BI has been shown to activate eNOS, although the responsible HDL entities and signaling pathways have remained enigmatic. Here we show that HDL stimulates NO release in human endothelial cells and induces vasodilation in isolated aortae via intracellular Ca2+ mobilization and Akt-mediated eNOS phosphorylation. The vasoactive effects of HDL could be mimicked by three lysophospholipids present in HDL: sphingosylphosphorylcholine (SPC), sphingosine-1-phosphate (S1P), and lysosulfatide (LSF). All three elevated intracellular Ca2+ concentration and activated Akt and eNOS, which resulted in NO release and vasodilation. Deficiency of the lysophospholipid receptor S1P3 (also known as LPB3 and EDG3) abolished the vasodilatory effects of SPC, S1P, and LSF and reduced the effect of HDL by approximately 60%. In endothelial cells from S1P3-deficient mice, Akt phosphorylation and Ca2+ increase in response to HDL and lysophospholipids were severely reduced. In vivo, intra-arterial administration of HDL or lysophospholipids lowered mean arterial blood pressure in rats. In conclusion, we identify HDL as a carrier of bioactive lysophospholipids that regulate vascular tone via S1P3-mediated NO release. This mechanism may contribute to the vasoactive effect of HDL and represent a novel aspect of its antiatherogenic function.

667 citations

Journal ArticleDOI
Simone Wahl, Alexander W. Drong1, Benjamin Lehne2, Marie Loh3, Marie Loh2, Marie Loh4, William R. Scott5, William R. Scott2, Sonja Kunze, Pei-Chien Tsai6, Janina S. Ried, Weihua Zhang2, Weihua Zhang7, Youwen Yang2, Sili Tan8, Giovanni Fiorito9, Lude Franke10, Simonetta Guarrera9, Silva Kasela11, Jennifer Kriebel, Rebecca C Richmond12, Marco Adamo13, Uzma Afzal2, Uzma Afzal7, Mika Ala-Korpela12, Mika Ala-Korpela3, Mika Ala-Korpela14, Benedetta Albetti15, Ole Ammerpohl16, Jane F. Apperley2, Marian Beekman17, Pier Alberto Bertazzi15, S. Lucas Black2, Christine Blancher1, Marc Jan Bonder10, Mario Brosch18, Maren Carstensen-Kirberg19, Anton J. M. de Craen17, Simon de Lusignan20, Abbas Dehghan21, Mohamed Elkalaawy13, Krista Fischer11, Oscar H. Franco21, Tom R. Gaunt12, Jochen Hampe18, Majid Hashemi13, Aaron Isaacs21, Andrew Jenkinson13, Sujeet Jha22, Norihiro Kato, Vittorio Krogh, Michael Laffan2, Christa Meisinger, Thomas Meitinger23, Zuan Yu Mok8, Valeria Motta15, Hong Kiat Ng8, Zacharoula Nikolakopoulou5, Georgios Nteliopoulos2, Salvatore Panico24, Natalia Pervjakova11, Holger Prokisch23, Wolfgang Rathmann19, Michael Roden19, Federica Rota15, Michelle Ann Rozario8, Johanna K. Sandling25, Johanna K. Sandling26, Clemens Schafmayer, Katharina Schramm23, Reiner Siebert16, Reiner Siebert27, P. Eline Slagboom17, Pasi Soininen3, Pasi Soininen14, Lisette Stolk21, Konstantin Strauch28, E-Shyong Tai8, Letizia Tarantini15, Barbara Thorand, Ettje F. Tigchelaar10, Rosario Tumino, André G. Uitterlinden21, Cornelia M. van Duijn21, Joyce B. J. van Meurs21, Paolo Vineis, Ananda R. Wickremasinghe29, Cisca Wijmenga10, Tsun-Po Yang26, Wei Yuan6, Wei Yuan30, Alexandra Zhernakova10, Rachel L. Batterham13, George Davey Smith12, Panos Deloukas31, Panos Deloukas32, Panos Deloukas26, Bastiaan T. Heijmans17, Christian Herder19, Albert Hofman21, Cecilia M. Lindgren1, Cecilia M. Lindgren33, Lili Milani11, Pim van der Harst10, Annette Peters, Thomas Illig, Caroline L Relton12, Melanie Waldenberger, Marjo-Riitta Järvelin34, Valentina Bollati15, Richie Soong8, Tim D. Spector6, James Scott5, Mark I. McCarthy1, Mark I. McCarthy35, Mark I. McCarthy36, Paul Elliott2, Paul Elliott37, Jordana T. Bell6, Giuseppe Matullo9, Christian Gieger, Jaspal S. Kooner5, Harald Grallert, John C. Chambers 
05 Jan 2017-Nature
TL;DR: In this article, the authors used epigenome-wide association to show that body mass index (BMI), a key measure of adiposity, is associated with widespread changes in DNA methylation.
Abstract: Approximately 1.5 billion people worldwide are overweight or affected by obesity, and are at risk of developing type 2 diabetes, cardiovascular disease and related metabolic and inflammatory disturbances1,2. Although the mechanisms linking adiposity to associated clinical conditions are poorly understood, recent studies suggest that adiposity may influence DNA methylation3,4,5,6, a key regulator of gene expression and molecular phenotype7. Here we use epigenome-wide association to show that body mass index (BMI; a key measure of adiposity) is associated with widespread changes in DNA methylation (187 genetic loci with P < 1 × 10−7, range P = 9.2 × 10−8 to 6.0 × 10−46; n = 10,261 samples). Genetic association analyses demonstrate that the alterations in DNA methylation are predominantly the consequence of adiposity, rather than the cause. We find that methylation loci are enriched for functional genomic features in multiple tissues (P < 0.05), and show that sentinel methylation markers identify gene expression signatures at 38 loci (P < 9.0 × 10−6, range P = 5.5 × 10−6 to 6.1 × 10−35, n = 1,785 samples). The methylation loci identify genes involved in lipid and lipoprotein metabolism, substrate transport and inflammatory pathways. Finally, we show that the disturbances in DNA methylation predict future development of type 2 diabetes (relative risk per 1 standard deviation increase in methylation risk score: 2.3 (2.07–2.56); P = 1.1 × 10−54). Our results provide new insights into the biologic pathways influenced by adiposity, and may enable development of new strategies for prediction and prevention of type 2 diabetes and other adverse clinical consequences of obesity.

667 citations

Journal ArticleDOI
TL;DR: It is demonstrated that psychosocial stress impairs memory retrieval in humans and suggests that emotionally arousing material is especially sensitive to this effect.
Abstract: Glucocorticoids (GCs) are known to modulate memory in animals and humans. One popular model suggests that stress or GC treatment enhances memory consolidation while impairing delayed memory retrieval. Studies in humans have documented that treatment with GCs impairs delayed memory retrieval. Similar alterations after exposure to stress have not been observed thus far. In the present study, 19 young healthy male subjects were exposed to either a standardized psychosocial laboratory stressor (Trier Social Stress Test) or a control condition in a crossover manner. After both treatments, retrieval of a word list (learned 24 h earlier) containing 10 neutral, 10 negative, and 10 positive words was tested. The stressor induced a significant increase in salivary free cortisol and a decrease in mood. Memory retrieval (free recall) was significantly impaired after the stress condition. Follow-up analysis revealed that negative and positive words (i.e., emotionally arousing words) were affected, whereas no effect was observed for neutral words. No changes were detected for cued recall, working memory, or attention. The present study thus demonstrates that psychosocial stress impairs memory retrieval in humans and suggests that emotionally arousing material is especially sensitive to this effect.

666 citations

Journal ArticleDOI
TL;DR: In this paper, a broad comparison of the data on party membership in European democracies and analyse changes in membership over time, comparing con- temporary levels with those from both 1980 and the late 1990s, and exploring variations in national patterns.
Abstract: This article offers an overview of levels of party membership in European democ- racies at the end of the first decade of the twenty-first century and looks also at changes in these levels over time, comparing party membership today with figures from both 1980 and the late 1990s. While relying primarily on the direct and individual membership figures as reported by the parties themselves, the fit of the data with survey data is explored and it is concluded that the two perform well in terms of convergent validity.The differences between large and small democracies are examined, as well as old and new democracies, and it is found that levels of party membership are related to both the size and age of the democratic polity in question. Finally, the implications of the patterns observed in the membership data are discussed, and it is suggested that membership has now reached such a low ebb that it may no longer constitute a relevant indicator of party organisational capacity. This article offers an overview and initial analysis of the levels of party mem- bership in European democracies at the end of the first decade of the twenty- first century, and discusses the implications of changes in party membership for our understanding of models of party organisation. The first two sections provide a broad comparison of the data on party membership in European democracies and analyse changes in membership over time, comparing con- temporary levels with those from both 1980 and the late 1990s, and exploring variations in national patterns. In the third section, we discuss some of the implications of the patterns that we observe in the membership data and suggest that membership has now reached such a low ebb that it may no longer constitute a relevant indicator of party organisational capacity. Alternatively, if membership continues to be regarded as offering a meaningful gauge of party organisational strength, we might then conclude that party organisations have reached such a low ebb that the formal organisational level is itself no longer a relevant indicator of party capacity. In presenting an overview of the levels of party membership in European democracies at the end of the first decade of the twenty-first century, our 24

663 citations


Authors

Showing all 25575 results

NameH-indexPapersCitations
Karl J. Friston2171267217169
Roderick T. Bronson169679107702
Stanley B. Prusiner16874597528
Ralph A. DeFronzo160759132993
Monique M.B. Breteler15954693762
Thomas Meitinger155716108491
Karl Zilles13869272733
Ruben C. Gur13674161312
Alexis Brice13587083466
Michael Schmitt1342007114667
Michael Weller134110591874
Helmut Sies13367078319
Peter T. Fox13162283369
Yuri S. Kivshar126184579415
Markus M. Nöthen12594383156
Network Information
Related Institutions (5)
Ludwig Maximilian University of Munich
161.5K papers, 5.7M citations

97% related

Heidelberg University
119.1K papers, 4.6M citations

96% related

University of Zurich
124K papers, 5.3M citations

95% related

University of Pittsburgh
201K papers, 9.6M citations

94% related

National Institutes of Health
297.8K papers, 21.3M citations

94% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
2023139
2022470
20213,130
20202,720
20192,507
20182,439